Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Wyeth Pharmaceuticals is searching for an agency to handle ad duties on a new generation of the estrogen-replacement drug Premarin, sources said.
The new formula, Premarin TMG, is expected to hit the market in 2004, according to an RFP from the Wayne, Pa., company.
The RFP, which was due back at the client on July 24, did not specify a budget for the assignment, which is said to focus on doctor-targeted advertising. There is, however, a small, direct-to-consumer component.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in